Encephalitis with radial perivascular emphasis: Not necessarily associated with GFAP antibodies

Jonathan Wickel1, Ha-Yeun Chung2, Klaus Kirchhof2

  • 1From the Hans Berger Department of Neurology (J.W., H.-Y.C., C.G., A.G.), Section of Translational Neuroimmunology, Jena University Hospital Germany; Department of Neuroradiology (K.K.), Jena University Hospital, Germany; Department of Neurology (D.B.), Sana Hospital Borna, Germany; Department of Neurology (S.M.), Heinrich-Braun Hospital, Zwickau; and Department of Neuropathology (P.K., W.C.M.), Leipzig University Hospital, Germany. jonathan.wickel@med.uni-jena.de.

Abstract

Insights

Autoimmune steroid-responsive meningoencephalomyelitis may include cases without anti-glial fibrillary acidic protein (GFAP) antibodies. This suggests the clinical spectrum of GFAP astrocytopathy is broader than previously recognized.

Area of Science:

  • Neuroimmunology
  • Neurology

Background:

  • Autoimmune steroid-responsive meningoencephalomyelitis is often linked to glial fibrillary acidic protein (GFAP) astrocytopathy.
  • This condition is typically characterized by the presence of anti-GFAP antibodies (ABs).

Observation:

  • Two patients presented with similar subacute influenza-like symptoms, severe neurocognitive deficits, and impaired consciousness.
  • Brain MRI revealed radial perivascular gadolinium enhancement suggestive of GFAP astrocytopathy in both patients.
  • One patient tested positive for anti-GFAP ABs, while the other was seronegative.

Findings:

  • Both patients responded well to high-dose methylprednisolone treatment.
  • Neuropathology in the seronegative patient showed perivascular infiltration of immune cells and microglial activation.
  • The clinical presentation and treatment response were similar despite differing antibody status.

Implications:

  • The findings suggest that the clinical spectrum of steroid-responsive meningoencephalomyelitis suggestive of GFAP astrocytopathy may encompass seronegative cases.
  • This broadens the understanding of GFAP astrocytopathy and its potential diagnostic criteria.
  • Further research is needed to elucidate the mechanisms behind seronegative GFAP astrocytopathy.

Related Concept Videos